CEM protocol

DIAGNOSTIC_TEST3 trials

Sponsors

Rehab Werida, Graziella di Grezia

Conditions

Breast Cancer DetectionBreast Cancer DiagnosisBreast Cancer PreventionLymphoma

Unknown Phase

BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation

CompletedNCT05813132

Rehab WeridaLymphoma

Start: 2022-11-11End: 2023-12-30Updated: 2024-09-05

Contrast Enhanced Mammography or Breast Magnetic Resonance: Which Choice for Optimal Diagnostic Performance?

Enrolling by invitationNCT06843083

Graziella di GreziaBreast Cancer Diagnosis, Breast Cancer Prevention

Start: 2025-02-01End: 2026-01-31Target: 350Updated: 2025-02-24

Second-Look Ultrasound Post Contrast-Enhanced Mammography for Additional Lesions Characterization

Enrolling by invitationNCT06846814

Graziella di GreziaBreast Cancer Detection, Breast Cancer Diagnosis

Start: 2025-01-01End: 2026-01-31Target: 350Updated: 2025-02-26

Related Papers

Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation.

2024-08-13